Authors

• Hillary Mulder (ORCID: https://orcid.org/0000-0003-4838-582X)
• Panagiotis Papavasileiou (ORCID: https://orcid.org/0000-0002-9655-9612)
• Megan L. Neely (ORCID: https://orcid.org/0000-0002-0101-1081)
• Jamie L. Todd (ORCID: https://orcid.org/0000-0003-4247-3693)
• Aravind Menon (ORCID: https://orcid.org/0000-0002-0211-4509)
• Christian Heßlinger
• Margaret L. Salisbury (ORCID: https://orcid.org/0000-0001-8217-6955)
• Felix Meissner (ORCID: https://orcid.org/0000-0003-1000-7989)
• Thomas B. Leonard (ORCID: https://orcid.org/0000-0003-3098-4330)
• Brian D. Southern (ORCID: https://orcid.org/0000-0003-2983-5741)
• Benedikt Gansen

Institutions

• Cleveland Clinic (US)
• Boehringer Ingelheim (Germany) (DE)
• Medical University of South Carolina (US)
• Duke University (US)
• University Hospital Bonn (DE)
• Clinical Research Institute (US)
• Duke Medical Center (US)
• Max Planck Institute of Biochemistry (DE)
• Boehringer Ingelheim (United States) (US)
• Vanderbilt University Medical Center (US)

Publication Details

Journal

Respiratory Research

Published

2025-10-22

DOI

https://doi.org/10.1186/s12931-025-03377-5

Primary Topic

Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis

Type

article

Field-Weighted Citation Impact

0.00

Funders

• Boehringer Ingelheim
• University of California, Los Angeles
• Duke Clinical Research Institute